logo
welcome
University of Cambridge

University of Cambridge

Glaucoma drug shows promise against neurodegenerative diseases, animal studies suggest

University of Cambridge
Summary
Nutrition label

83% Informative

Researchers in the UK Dementia Research Institute at the University of Cambridge screened more than 1,400 clinically-approved drug compounds using zebrafish genetically engineered to make them mimic so-called tauopathies.

Tauopathies are neurodegenerative diseases characterised by the build-up in the brain of tau protein aggregates’ within nerve cells.

This will enable us to move to clinical trials much faster than we might normally expect if we were starting from scratch with an unknown drug compound.

“This shows how we can use zebrafish to test whether existing drugs might be repurposed to tackle different diseases, potentially speeding up significantly the drug discovery process.”.

VR Score

86

Informative language

88

Neutral language

60

Article tone

formal

Language

English

Language complexity

68

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

Source diversity

1

Affiliate links

no affiliate links